Drupal.behaviors.print = function(context) {window.print();window.close();}>
Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test
September 12, 2012
Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
HTG Molecular Dx Licenses PROOF Centre COPD Testing Tech
November 27, 2012 / GenomeWeb Daily News
Castle Biosciences Licenses BAP1 Gene from Wash U. for Melanoma Metastasis Detection
October 21, 2011 / GenomeWeb Daily News
TrovaGene Regains Ownership, Patent Control of Transrenal Technology
August 10, 2011 / GenomeWeb Daily News
CAP Accredits CardioDx's Laboratory
May 9, 2013 / GenomeWeb Daily News
GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News